Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Lumateperone in Pediatric Patients With Autism Spectrum Disorder [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the safety, tolerability, and pharmacokinetics of lumateperone in pediatric patients with autism spectrum disorder; rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Lumateperone (Caplyta) (lumateperone)

Snippet

Sponsor: Intra-Cellular Therapies, Inc. | Conditions: Autism Spectrum Disorder | Phase 1 | Status: RECRUITING